Strategic partnerships DiMe actively engages with major pharmaceutical and biotech players (Amgen Foundation, GSK, Medable, Rubix LS, Sage Bionetworks, THREAD Research) to drive inclusion in digital clinical trials and advance digital medicine initiatives, indicating a strong opportunity to offer collaboration platforms, inclusive trial solutions, and digital endpoint expertise.

Digital endpoint leadership With initiatives like DATAcc and the launch of digital measures for mental health, DiMe demonstrates a leadership role in developing and validating digital endpoints, creating a sales lead for measurement science services, data standards, and integration with clinical workflows.

Governance and compliance Recent joint AI governance toolkit with FDA signals a demand for governance, safety, and compliance frameworks in digital health, suggesting opportunities to sell governance tooling, risk management programs, and implementation support for health systems adopting AI.

Operational readiness The Post-Contracting Operational Readiness Toolkit project indicates a need for payer-provider-policy alignment and operational playbooks, presenting a chance to offer consulting, implementation services, and technology enablement around post-contract workflows.

Global non-profit scale DiMe’s global non-profit positioning and sizable revenue band, combined with a focus on equitable digital health, points to opportunities in sponsored programs, training, and capacity-building services for health systems and industry partners pursuing large-scale digital health initiatives.